ROSWELL, Ga., June 12, 2025 /PRNewswire/ — Buds Technology, a leading innovator in healthcare solutions, has officially launched AKSSI for Senior Living, an AI-powered Virtual Medical Assistant. This cutting-edge solution revolutionizes the way the senior living communities deliver care and streamline operations while enhancing the quality of life for residents and peace of mind for their families.
“Since introducing AKSSI into our care model, we’ve seen a remarkable transformation in how we support our residents and our staff,” said Brenda, Chief Operating Officer of Carriages at Carriage. “It’s like having a virtual nurse at the fingertips of our personal care assistants.”
AKSSI enables real-time, smart assessments performed by personal care aides. Any noticeable changes in a resident’s condition are automatically reported to licensed nurses, allowing for timely and accurate adjustments in care. This ensures that residents receive the appropriate level of support exactly when they need it—improving both safety and wellbeing.
Key benefits of AKSSI include:
“AKSSI’s automated alerts and data tracking have allowed our staff to focus more on meaningful resident interaction and less on paperwork. It even reduces stress for families by ensuring supplies are consistently stocked and by providing timely health updates,” Brenda added.
The impact has been profound: fewer emergency situations, improved health outcomes, and enhanced operational efficiency. For assisted living communities seeking to modernize and elevate their care, AKSSI offers a proven, scalable solution.
“We believe AKSSI represents the future of assisted living,” said Farrokh Abadi, COO of Buds Technology. “Our mission is to support care teams by giving them tools that reduce stress, enhance communication, and most importantly, improve outcomes for residents.”
AKSSI is now available for assisted living communities across the United States. Facilities interested in improving care efficiency and resident safety can schedule a free demo at www.budstechnology.com.
For PR inquiries or marketing opportunities please reach out to Anna Boisse at anna@budstechnology.com Follow BUDS Technology on LinkedIn for ongoing updates.
Media Contact:
Anna Boisse
Buds Technology
SOURCE BUDS Technology
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo…
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo…
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…
Label-verified GaraHerb ingredient disclosures, manufacturing and policy transparency details, and what consumers searching for GaraHerb…
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…
An informational overview examining category context, publicly available product disclosures, and what consumers often consider…